新型コロナウイルス中和抗体測定キット SARS-CoV-2 Neutralizing Antibody Detection ELISA Kit
（Cayman社 ）

SARS-CoV-2の基本構造

SARS-CoV-2のSpike糖タンパク質とは

ACE2とは

SARS-CoV-2とACE2との相互作用と中和抗体について

参考文献

1. Kandeel, M., Ibrahim, A., Fayez, M., et al., "From SARS and MERS CoVs to SARS-CoV-2: Moving toward more biased codon usage in viral structural and nonstructural genes.", J. Med. Virol., 92(6), 660～666 (2020).
2. Lu, R., Zhao, X., Li, J., et al., "Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding.", Lancet, 395(10224), 565～574 (2020).
3. Meo, S.A., Alhowikan, A.M., Al-Khlaiwi, T., et al., "Novel coronavirus 2019- nCoV: Prevalence, biological and clinical characteristics comparison with SARS-CoV and MERS-CoV.", Eur. Rev. Med. Pharmacol. Sci., 24(4), 2012～2019 (2020).
4. Klok, F.A., Kruip, M.J.H.A., van der Meer, N.J.M., et al., "Incidence of thrombotic complications in critically ill ICU patients with COVID-19.", Thromb. Res., 191, 145～147 (2020).
5. Yang, F., Shi, S., Zhu, J., et al., "Analysis of 92 deceased patients with COVID-19.", J. Med. Virol. (2020).
6. Liu, Z., Xiao, X., Wei, X., et al., "Composition and divergence of coronavirus spike proteins and host ACE2 receptors predict potential intermediate hosts of SARS-CoV-2.", J. Med. Virol., 92(6), 595～601 (2020).
7. Walls, A.C., Park, Y.-J., Tortorici, M.A., et al., "Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein.", Cell, 181(2), 281～292 (2020).
8. Hoffmann, M., Kleine-Weber, H., Schroeder, S., et al., "SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor.", Cell, 181(2), 271～280 (2020).
9. Yan, R., Zhang, Y., Li, Y., et al., "Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2.", Science, 267(6485), 1444～1448 (2020).
10. Wrapp, D., Wang, N., Corbett, K.S., et al., "Cryo-EM structure of the 2019- nCov spike in the prefusion conformation.", Science, 367(6483), 1260～1263 (2020).
11. Bestle, D., Heindl, M.R., Limburg, H., et al., "TMPRSS2 and furin are both essential for proteolytic activation of SARS-CoV-2 in human airway cells.", Life Sci. Alliance, 3(9), e202000786 (2020).
12. Shang, J., Wan, Y., Luo, C., et al., "Cell entry mechanisms of SARS-CoV-2.", PNAS, 117(21), 11727～11734 (2020).
13. Perlot, T. and Penninger, J.M. "ACE2-From the renin-angiotensin system to gut microbiota and malnutrition.", Microbes Infect., 15(13), 866～873 (2013).
14. Verdecchia, P., Cavallini, C., Spanevello, A., et al., "The pivotal link between ACE2 deficiency and SARS-CoV-2 infection.", Eur. J. Intern. Med., 76, 14～20 (2020).
15. Monteil, V., Kwon, H., Prado, P., et al., "Inhibition of SARS-CoV-2 infections in engineered human tissues using clinical-grade soluble human ACE2.", Cell, 181(4), 1～9 (2020).
16. Wang, A., Zhang, L., Sang, L., et al., "Kinetics of viral load and antibody response in relation to COVID-19 severity, J. Clin. Invest., 130(10), 5235～5244 (2020).
17. Xiang, F., Wang, X., He, X., et al., "Antibody detection and dynamic characteristics in patients with coronavirus disease 2019.", Clin. Infect. Dis., ciaa461 (2020).
18. Li, L., Tong, X., Chen, H., et al., "Characteristics and serological patterns of COVID-19 convalescent plasma donors: Optimal donors and timing of donation.", Transfusion, DOI: 10.1111/trf.15918 (2020).
19. Long, Q.-X., Tang, X.-J., Shi, Q.-L. et al., "Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections.", Nat. Med., 26, 1200～1204 (2020).